NeuroRPM is a digital health technology company building a mobile health and data analytics platform to optimize clinical care for sufferers of neurodegenerative diseases. NeuroRPM is based in Washington D.C. Our mission is to digitally reshape and improve the model of care for a broad range of neurodegenerative diseases by integrating the NeuroRPM platform and analytical tools with doctors, patients, and industry partners. The NeuroRPM system is currently in clinical trials with participating partners.

​

On March 17, 2023, NeuroRPM was cleared by the FDA for use to monitor Parkinson's disease on Apple Watch for Parkinson's disease. You may read the press release. 

 

You may register with us to learn more about our technology and get updates as they happen.  Please follow this link to register with us.